Don Button

Don is Vice President, Biology at Switch Therapeutics and works closely with the technology platform development team to utilize Switch’s unique RNAi therapeutics for making new drugs to address unmet medical needs. He trained as a molecular pharmacologist and has 20+ years of industry experience in drug discovery and development, focused on orally available small molecules, protein therapeutics and oligonucleotide drugs for indications in the central nervous system, cardiovascular and immune systems